ISO 11608-3:2022

Overview

ISO 11608-3:2022 - Needle-based injection systems for medical use - Part 3: Containers and integrated fluid paths - specifies requirements and test methods for design verification of containers (e.g., cartridges, syringes, prefilled syringes) and integrated fluid paths used with needle-based injection systems (NISs). This third edition (2022) updates and replaces the 2012 edition and is intended for single- and multi‑dose containers that are manufacturer‑filled (primary container closure) or user‑filled (reservoir). It explicitly excludes sterile hypodermic needles/syringes intended for single-use insulin products, refillable containers, dental containers, and separately attached catheters/infusion sets.

Key topics and technical requirements

ISO 11608-3:2022 focuses on design verification areas critical to safe delivery of medicinal products via NIS:

• Container Closure Integrity (CCI) - ensuring the primary container closure maintains a sterile barrier until expiry or first user interaction.
• Resealability - requirements and test methods for multi‑dose cartridges/reservoirs with discs to prevent contamination after repeated access.
• Fragmentation (disc coring) - evaluation of elastomeric particle generation when closures are pierced (risk to drug product and patient).
• Cannula and fluid path requirements - specifications for rigid needles and soft cannulas as part of the integrated fluid path.
• Fluid line connections - compatibility and secure connections for integrated paths.
• Medicinal product compatibility - assessment of materials with respect to particulates, pyrogenicity, leachables, and sterilization impacts.
• Medicinal product leakage - design and test considerations to prevent unintended leakage.
• Test methods and documentation - defined test methods for resealability, fragmentation, sub‑visible/visible particulates and information to be supplied with the container.
• Informative annexes provide guidance on compatibility references, theoretical support for resealability, leachables, and historical references.

Practical applications - who uses this standard

ISO 11608-3:2022 is essential for:

• Medical device designers and engineers developing NIS (pens, auto‑injectors, bolus devices).
• Pharmaceutical companies and contract manufacturers verifying container–device compatibility for parenteral drug products.
• Quality, regulatory and compliance teams preparing design verification dossiers, risk assessments, and submission packages.
• Suppliers of cartridges, syringes, elastomeric closures, cannulas and integrated fluid paths validating components to recognized international criteria.

Typical uses include design verification testing, supplier qualification, risk‑based material selection (to control leachables and particulates), and preparing regulatory evidence for market approval.

Related standards

Relevant cross‑references cited in ISO 11608-3:2022 include:

• ISO 11608-1 (NIS general requirements)
• ISO 11040 series (prefilled syringes)
• ISO 13926 series (cartridges, stoppers, seals)
• ISO 11607 (packaging for sterile devices)
• ISO 10993 parts on biological evaluation (leachables/toxicity)

Keywords: ISO 11608-3:2022, needle-based injection systems, containers, integrated fluid paths, cartridge resealability, container closure integrity, disc coring, leachables, particulates, design verification.